The tumor marker CA-125 is one of the most commonly used biomarkers in the diagnosis of ovarian cancer, but its sensitivity and specificity are variable depending on the diagnostic threshold used and the stage of the disease. This evidence concerns the gene MUC16 and neoplasm.